SHENZHEN JYMED TECHNOLOGY CO LTD

Overview

SHENZHEN JYMED TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 12 active FDA Type II Drug Master Files, covering BOC-HIS(TRT)-AIB-GLU(OTBU)-GLY-OH; DEGARELIX ACETATE; FMOC-LYS[TBUO-STE-GLU(AEEA-AEEA)-OTBU]-OH; LIRAGLUTIDE; NATURAL KILLER CELLS ACTIVATION AND EXPANSION KIT; OXYTOCIN.

API / Drug Master Files

SHENZHEN JYMED TECHNOLOGY CO LTD holds 12 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SEMAGLUTIDE (PROCESS IV)Active2026-02-05
• NATURAL KILLER CELLS ACTIVATION AND EXPANSION KITActive2025-09-17
• FMOC-LYS[TBUO-STE-GLU(AEEA-AEEA)-OTBU]-OHActive2025-01-19
• SEMAGLUTIDE (PROCESS II)Active2025-01-17
• BOC-HIS(TRT)-AIB-GLU(OTBU)-GLY-OHActive2025-01-16
• SEMAGLUTIDE (PROCESS III)Active2025-01-08
• TERIPARATIDEActive2025-01-06
• TIRZEPATIDEActive2024-07-18
• SEMAGLUTIDEActive2022-05-04
• OXYTOCINActive2020-12-29
• LIRAGLUTIDEActive2019-09-27
• DEGARELIX ACETATEActive2019-02-21

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHENZHEN JYMED TECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.